SNT 0.00% 4.3¢ syntara limited

Ann: Half Yearly Report and Accounts, page-6

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 132 Posts.
    lightbulb Created with Sketch. 22
    From the 1/2yr report.... "Large pharmaceutical companies are interested in the SSAO enzyme for its role in various inflammatory diseases such as non-alcoholic steatohepatitis (NASH) and chronic obstructive pulmonary disease (COPD). Term sheets have been received and the Company is currently at the contract negotiation stage."

    ....Contract negotiation stage..... wont be far off a further announcement.
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
4.3¢
Change
0.000(0.00%)
Mkt cap ! $59.04M
Open High Low Value Volume
4.3¢ 4.3¢ 4.2¢ $20.22K 474.7K

Buyers (Bids)

No. Vol. Price($)
1 25780 4.2¢
 

Sellers (Offers)

Price($) Vol. No.
4.4¢ 581744 4
View Market Depth
Last trade - 15.54pm 11/10/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.